Ame Company For Medical Supplies

9527.SRSAUHealthcare● Active

$73.00

$-1.00(-1.35%)

Market Cap$511000000

P/E Ratio—

52W High$140

52W Low$70

Avg Volume5K

Open$74.00

Beta-0.06

Free Cash Flow Financials Revenue

Ame Company For Medical Supplies (9527.SR) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

9527.SR · free cash flow · updated Jun 15, 2026

Core FCF metrics

9527.SR · FCF · TTM · margin & CAGR

Free cash flow was −$26.8M for FY2025 (fiscal year ending 2025-12-31), down 585.9% year-over-year The FCF margin was -8.8%.

FY2025 Free Cash Flow−$26.8M▼ -585.9% YoY

Trailing 12M (TTM)−$11.1Mtrailing 4 quarters sum

FCF Margin-8.8%−$26.8M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 15, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

9527.SR · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$26.0M(1M)−$26.8M▼ 585.9%-8.8%

FY2024−$3.6M(0M)−$3.9M▼ 111.2%-1.6%

FY2023$36.7M(2M)$34.7M▲ +353.3%15.6%

FY2022$8.5M(1M)$7.7M▼ 61.6%4.0%

FY2021$20.3M(0M)$19.9M▲ +76.2%13.2%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

9527.SR · P/FCF · FCF yield · FCF per share

Ame Company For Medical Supplies (9527.SR) reported negative free cash flow of −$0.03B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

9527.SR · cash flow statement · operating / investing / financing

For FY2025, Ame Company For Medical Supplies generated −$26.0M in operating cash flow and spent 1M in capital expenditures, yielding −$26.8M in free cash flow.

Operating Activities

−$26.0M

Cash from core business operations

2025-12-31

Investing Activities

−$1.2M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$12.7M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$26.0M) − |CapEx| (1M) = FCF (−$26.8M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

9527.SR vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Ame Company For Medical SuppliesYOU

9527.SR

−$26.8M-585.9%-8.8%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Ame Company For Medical Supplies (9527.SR) reported free cash flow of −$26.8M for FY2025 (fiscal year ending 2025-12-31), down 585.9% year-over-year. The FCF margin was -8.8%.

Based on available data, Ame Company For Medical Supplies has maintained positive free cash flow for at least 5 fiscal year(s). FCF peaked at $34.7M in FY2023.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

9527.SR free cash flow · 8 questions

Ame Company For Medical Supplies free cash flow was −$26.8M for FY2025, down 585.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$11.1M.

9527.SR free cash flow9527.SR FCF9527.SR FCF 20259527.SR free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Ame Company For Medical Supplies · Ame Company For Medical Supplies SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 15, 2026